Detalhe da pesquisa
1.
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report.
Haematologica
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38721751
2.
Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice.
J Transl Med
; 18(1): 451, 2020 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256746
3.
Evaluation of lymphocytes inactivation by extracorporeal photopheresis using tetrazolium salt based-assay.
Transfus Apher Sci
; 53(2): 242-5, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26051797
4.
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study.
Am J Hematol
; 89(12): 1085-91, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25159313
5.
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia.
Stem Cell Res Ther
; 12(1): 316, 2021 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34078447
6.
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study.
Lancet Haematol
; 7(12): e861-e873, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33242443
7.
Hemostatic complications of angiogenesis inhibitors in cancer patients.
Am J Hematol
; 83(11): 862-70, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18819092
8.
Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
Haematologica
; 89(9): 1141-2, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15377478
9.
KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication.
Haematologica
; 89(8): 920-5, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15339674
10.
Side effects of anti-angiogenic drugs.
Thromb Res
; 129 Suppl 1: S50-3, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22682133
11.
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
J Clin Oncol
; 29(8): 986-93, 2011 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21282540
12.
Effect of DCEP mobilizing regimen in in vivo purging of PBSC harvests in multiple myeloma.
Leuk Lymphoma
; 45(7): 1497-9, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15359659
13.
Thrombosis associated with angiogenesis inhibitors.
Best Pract Res Clin Haematol
; 22(1): 115-28, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19285278
14.
Thrombotic events in patients with cancer receiving antiangiogenesis agents.
J Clin Oncol
; 27(29): 4865-73, 2009 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19704059
15.
Thrombosis in multiple myeloma.
Expert Rev Anticancer Ther
; 7(3): 307-15, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17338651
16.
Hemostatic dysfunction in paraproteinemias and amyloidosis.
Semin Thromb Hemost
; 33(4): 339-49, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17525891
17.
Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients.
Am J Hematol
; 82(9): 831-3, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17546639
18.
Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism.
Br J Haematol
; 134(4): 399-405, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16882132
19.
Prolonged overall survival with second on-demand autologous transplant in multiple myeloma.
Am J Hematol
; 81(6): 426-31, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16680735
20.
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.
Blood
; 107(9): 3463-8, 2006 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16384925